Gage BF - Search Results

1

Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy.

Ferder NS, Eby CS, Deych E, Harris JK, Ridker PM, Milligan PE, Goldhaber SZ, King CR, Giri T, McLeod HL, Glynn RJ, Gage BF. Ferder NS, et al. Among authors: gage bf. J Thromb Haemost. 2010 Jan;8(1):95-100. doi: 10.1111/j.1538-7836.2009.03677.x. Epub 2009 Oct 30. J Thromb Haemost. 2010. PMID: 19874474 Free PMC article. Clinical Trial.

2

Management and dosing of warfarin therapy.

Gage BF, Fihn SD, White RH. Gage BF, et al. Am J Med. 2000 Oct 15;109(6):481-8. doi: 10.1016/s0002-9343(00)00545-3. Am J Med. 2000. PMID: 11042238 Review.

3

Warfarin therapy for an octogenarian who has atrial fibrillation.

Gage BF, Fihn SD, White RH. Gage BF, et al. Ann Intern Med. 2001 Mar 20;134(6):465-74. doi: 10.7326/0003-4819-134-6-200103200-00011. Ann Intern Med. 2001. PMID: 11255522 Review.

4

Patient and physician satisfaction with a telephone-based anticoagulation service.

Waterman AD, Banet G, Milligan PE, Frazier A, Verzino E, Walton B, Gage BF. Waterman AD, et al. Among authors: gage bf. J Gen Intern Med. 2001 Jul;16(7):460-3. doi: 10.1046/j.1525-1497.2001.016007460.x. J Gen Intern Med. 2001. PMID: 11520383 Free PMC article. Clinical Trial.

5

Establishing and running an effective telephone-based anticoagulation service.

Waterman AD, Milligan PE, Banet GA, Gatchel SK, Gage BF. Waterman AD, et al. Among authors: gage bf. J Vasc Nurs. 2001 Dec;19(4):126-32; quiz 133-4. doi: 10.1067/mvn.2001.119940. J Vasc Nurs. 2001. PMID: 11734798

6

Substitution of generic warfarin for Coumadin in an HMO setting.

Milligan PE, Banet GA, Waterman AD, Gatchel SK, Gage BF. Milligan PE, et al. Among authors: gage bf. Ann Pharmacother. 2002 May;36(5):764-8. doi: 10.1345/aph.1A327. Ann Pharmacother. 2002. PMID: 11978149 Clinical Trial.

7

Warfarin dose reduction vs watchful waiting for mild elevations in the international normalized ratio.

Banet GA, Waterman AD, Milligan PE, Gatchel SK, Gage BF. Banet GA, et al. Among authors: gage bf. Chest. 2003 Feb;123(2):499-503. doi: 10.1378/chest.123.2.499. Chest. 2003. PMID: 12576372 Clinical Trial.

8

Risk factors for bleeding in patients taking coumarins.

Beyth RJ, Milligan PE, Gage BF. Beyth RJ, et al. Among authors: gage bf. Curr Hematol Rep. 2002 Sep;1(1):41-9. Curr Hematol Rep. 2002. PMID: 12901124 Review.

9

Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin.

Gage BF, Eby C, Milligan PE, Banet GA, Duncan JR, McLeod HL. Gage BF, et al. Thromb Haemost. 2004 Jan;91(1):87-94. doi: 10.1160/TH03-06-0379. Thromb Haemost. 2004. PMID: 14691573

10

Perioperative reduction of the warfarin dose.

Milligan PE, Banet GA, Gage BF. Milligan PE, et al. Among authors: gage bf. Am J Med. 2003 Dec 15;115(9):741-2. doi: 10.1016/j.amjmed.2003.06.002. Am J Med. 2003. PMID: 14693332 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters